(Q37874052)

24 August 2017

1 reference

title

Diabetes and cardiovascular disease interventions by community pharmacists: a systematic review (English)

1 reference

24 August 2017

main subject

cardiovascular disease

1 reference

1 reference

2

Erin Watson

1 reference

24 August 2017

Charity D Evans

1

1 reference

24 August 2017

Dean T Eurich

3

1 reference

24 August 2017

Jeff G Taylor

4

1 reference

24 August 2017

Erin M Yakiwchuk

5

1 reference

24 August 2017

Yvonne M Shevchuk

6

1 reference

24 August 2017

Alfred Remillard

7

1 reference

24 August 2017

David Blackburn

8

1 reference

24 August 2017

language of work or name

English

0 references

publication date

10 May 2011

1 reference

Annals of Pharmacotherapy

24 August 2017

published in

1 reference

24 August 2017

volume

45

1 reference

24 August 2017

issue

5

1 reference

24 August 2017

page(s)

615-628

1 reference

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

24 August 2017

cites work

1 reference

Sensitivity of patient outcomes to pharmacist interventions. Part II: Systematic review and meta-analysis in hypertension management

21 January 2018

1 reference

Systematic reviews of pharmacy practice research: methodologic issues in searching, evaluating, interpreting, and disseminating results

21 January 2018

1 reference

Effects of pharmacist outpatient interventions on adults with diabetes mellitus: a systematic review

21 January 2018

1 reference

Sensitivity of patient outcomes to pharmacist interventions. Part III: systematic review and meta-analysis in hyperlipidemia management

21 January 2018

1 reference

Sensitivity of patient outcomes to pharmacist interventions. Part I: systematic review and meta-analysis in diabetes management

21 January 2018

1 reference

Systematic review of the effectiveness of community pharmacy-based interventions to reduce risk behaviours and risk factors for coronary heart disease

21 January 2018

1 reference

The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions

21 January 2018

1 reference

Randomized, controlled trials, observational studies, and the hierarchy of research designs

21 January 2018

1 reference

Psychosocial interventions in people with multiple sclerosis: a review

21 January 2018

1 reference

Impact of a pharmaceutical care program in a community pharmacy on patients with dyslipidemia

21 January 2018

1 reference

Community pharmacist-provided extended diabetes care.

21 January 2018

1 reference

The Diabetes Ten City Challenge: interim clinical and humanistic outcomes of a multisite community pharmacy diabetes care program

21 January 2018

1 reference

The Pharmacy Diabetes Care Program: assessment of a community pharmacy diabetes service model in Australia.

21 January 2018

1 reference

A pharmacotherapy follow-up program in patients with type-2 diabetes in community pharmacies in Spain.

21 January 2018

1 reference

Patient self-management program for diabetes: first-year clinical, humanistic, and economic outcomes

21 January 2018

1 reference

The Asheville Project: long-term clinical and economic outcomes of a community pharmacy diabetes care program

21 January 2018

1 reference

The Asheville Project: short-term outcomes of a community pharmacy diabetes care program

21 January 2018

1 reference

Improvement of diabetes indices of care by a short pharmaceutical care program.

21 January 2018

1 reference

Community pharmacy-based hypertension disease-management program in a Latino/Hispanic-American population.

21 January 2018

1 reference

Hypertension outcomes through blood pressure monitoring and evaluation by pharmacists (HOME study)

21 January 2018

1 reference

Evaluation of a pharmaceutical care program for hypertensive patients in rural Portugal.

21 January 2018

1 reference

Impact of a pharmaceutical care intervention on blood pressure control in a chain pharmacy practice

21 January 2018

1 reference

Two pharmacy interventions to improve refill persistence for chronic disease medications: a randomized, controlled trial

21 January 2018

1 reference

Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories.

21 January 2018

1 reference

Effect of a pharmacist-led intervention on diuretic compliance in heart failure patients: a randomized controlled study

21 January 2018

1 reference

A pharmaceutical care program to improve adherence to statin therapy: a randomized controlled trial.

21 January 2018

1 reference

Effect of community pharmacist intervention on cholesterol levels in patients at high risk of cardiovascular events: the Second Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP-plus).

21 January 2018

1 reference

Long-term impact of a community pharmacist intervention on cholesterol levels in patients at high risk for cardiovascular events: extended follow-up of the second study of cardiovascular risk intervention by pharmacists (SCRIP-plus).

21 January 2018

1 reference

The MEDMAN study: a randomized controlled trial of community pharmacy-led medicines management for patients with coronary heart disease

21 January 2018

1 reference

A randomized trial of the effect of community pharmacist intervention on cholesterol risk management: the Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP).

21 January 2018

1 reference

Implementation of pharmaceutical care services for patients with hyperlipidemias by independent community pharmacy practitioners.

21 January 2018

1 reference

Effectiveness of interventions by community pharmacists to improve patient adherence to chronic medication: a systematic review.

21 January 2018

1 reference

Critical analysis of the pharmaceutical care research literature

21 January 2018

1 reference

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials.

21 January 2018

1 reference

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies

21 January 2018

1 reference

Practice-based research: lessons from community pharmacist participants

21 January 2018

1 reference

Between intention and behavior: an application of community pharmacists' assessment of pharmaceutical care.

21 January 2018

1 reference

21 January 2018

1 reference

Effectiveness and acceptability of community pharmacy-based interventions in type 2 diabetes: a critical review of intervention design, pharmacist and patient perspectives

21 January 2018

1 reference

Pharmaceutical care services: a systematic review of published studies, 1990 to 2003, examining effectiveness in improving patient outcomes

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1P615

1 reference

24 August 2017

1 reference